P

Paolo Tarantino

Harvard University

ORCID: 0000-0001-8686-0228

Publishes on HER2/EGFR in Cancer Research, Advanced Breast Cancer Therapies, Breast Cancer Treatment Studies. 245 papers and 5.9k citations.

PubIndex Score97Top 3% · mid-careerHow it's scored

245Publications

5.9kTotal Citations

First publication: 1981First senior author: 2013

HER2/EGFR in Cancer Research Advanced Breast Cancer Therapies Breast Cancer Treatment Studies Monoclonal and Polyclonal Antibodies Research Cancer Treatment and Pharmacology

Top publicationsby citations

HER2-Low Breast Cancer: Pathological and Clinical Landscape

Paolo Tarantino, Giuseppe Curigliano, Frédérique Penault‐Llorca et al.|Journal of Clinical Oncology|2020

Cited by 801

Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life

Stefania Morganti, Giuseppe Curigliano, Paolo Tarantino et al.|Critical Reviews in Oncology/Hematology|2018

Cited by 149

Enhancing Breast Cancer Risk Prediction with Machine Learning: Integrating BMI, Smoking Habits, Hormonal Dynamics, and BRCA Gene Mutations—A Game-Changer Compared to Traditional Statistical Models?

Luana Conte, Elisabetta De Matteis, Emanuele Rizzo et al.|Applied Sciences|2024

Cited by 12

Opportunities and Challenges for a Histology-Agnostic Utilization of Trastuzumab Deruxtecan

Niraj Neupane, Paolo Tarantino, Sangharsha Thapa et al.|Current Oncology Reports|2023

Cited by 4

Exploring a Novel Approach to Spare Classic Chemotherapy in HER2-Low, ER-Positive Breast Cancer Based on Trastuzumab Deruxtecan Combined with Endocrine Therapy

Luca Scafuri, Giuseppe Di Lorenzo, Carlo Buonerba et al.|Oncology and Therapy|2024

Cited by 0